EGFR and neoplasm: In line with the aforementioned lines of evidence, the lowest expression of LIMT in both cohorts corresponded to patients diagnosed with basal‐like cancer (Fig 6A and Appendix Fig S1), an aggressive tumor frequently associated with high EGFR expression and mutations in the downstream pathways (Hoadley et al, 2007; Foulkes et al, 2010).